C-220 — An Act to amend the Food and Drugs Act (trans fatty acids)
Last action — Outside order precedence
No card. One bill, free forever — alerts when it moves.
-
✓Introduced
-
Died on the Order Paper
This bill died with 38-1 Parliament. It reached “Introduced” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.
Bill Text
- Bill text (openparliament.ca) View text October 18, 2004
Laws this bill changes
1 section in 1 lawFrom the bill's own amending clauses, matched to Justice Canada's consolidation of the Acts and regulations we hold. Open a section to read the law as it stands beside the clause that would change it, and the section as the bill would leave it, marked up by software as a reading aid.
Food and Drugs Act, R.S.C. 1985, c. F-27 1 section
-
s. 2 Definitions Amends
Food and Drugs Act, R.S.C. 1985, c. F-27, s. 2
The bill's clause
Section 2 of the Food and Drugs Act is amended by adding the following in alphabetical order: 1. L’article 2 de la Loi sur les aliments et drogues est modifié par adjonction, selon l’ordre alphabétique, de ce qui suit : “trans fatty acids” « acides gras trans » “trans fatty acids” means unsaturated fatty acids that contain one or more isolated or non-conjugated double bonds in a trans-configuration; « acides gras trans » Acides gras insaturés qui contiennent une ou plusieurs liaisons doubles isolées ou non conjuguées de configuration trans. « acides gras trans » “trans fatty acids” 2. The Act is amended by adding the following after section 5: 2. La même loi est modifiée par adjonction, après l’article 5, de ce qui suit : Application 5.1 (1) This section applies to oils and fats, including emulsions with fat as the continuous phase, that are intended for human consumption. 5.1 (1) Le présent article s’applique aux huiles et graisses, y compris les émulsions dont la phase continue est constituée par une matière grasse, qui sont destinées à la consommation humaine. Application Content of trans fatty acids in oils and fats (2) No person shall sell to a consumer any oil or fat that contains more than 2 grams of trans fatty acids per 100 grams of oil or fat. (2) Il est interdit de vendre à un consommateur toute huile ou graisse qui contient plus de 2 grammes d’acides gras trans par 100 grammes d’huile ou de graisse. Contenu des acides gras trans dans les huiles et graisses Content of trans fatty acids in other food (3) No person shall sell to a consumer any food that contains one or more ingredients in addition to oil or fat if the food contains more than 2 grams of trans fatty acids per 100 grams of oil or fat in the food. (3) Il est interdit de vendre à un consommateur tou…The law today
In this Act, advanced therapeutic product means a therapeutic product that is described in Schedule G or that belongs to a class of therapeutic products that is described in that Schedule; (produit thérapeutique innovant) advertisement includes any representation by any means whatever for the purpose of promoting directly or indirectly the sale or disposal of any food, drug, cosmetic or device; (publicité ou annonce) analyst means an individual designated as an analyst for the purposes of this Act under section 28 or under section 13 of the Canadian Food Inspection Agency Act; (analyste) clinical trial means a study, involving human subjects, for the purpose of discovering or verifying the effects of a drug, a device or a food for a special dietary purpose; (essai clinique) confidential business information, in respect of a person to whose business or affairs the information relates, means — subject to the regulations — business information (a) that is not publicly available, (b) in respect of which the person has taken measures that are reasonable in the circumstances to ensure that it remains not publicly available, and (c) that has actual or potential economic value to the person or their competitors because it is not publicly available and its disclosure would result in a material financial loss to the person or a material financial gain to their competitors; (renseignements commerciaux confidentiels) contraceptive device means any instrument, apparatus, contrivance or substance other than a drug, that is manufactured, sold or represented for use in the prevention of conception; (moyen anticonceptionnel) cosmetic includes any substance or mixture of substances manufactured, sold or represented for use in cleansing, improving or altering the complexion, skin, hair or teeth, and includes deodorants and perfumes; (cosmétique) Department means the Department of Health; (ministère) device means an instrument, apparatus, contrivance or other similar article, or an in vitro reagent, including a component, part or accessory of any of them, that is manufactured, sold or represented for use in (a) diagnosing, treating, mitigating or preventing a disease, disorder or abnormal physical state, or any of their symptoms, in human beings or animals, (b) restoring, modifying or correcting the body structure of human beings or animals or the functioning of any part of the bodies of human beings or animals, (c) diagnosing pregnancy in human beings or animals, (d) caring for human beings or animals during pregnancy or at or after the birth of the offspring, including caring for the offspring, or (e) preventing conception in human beings or animals;however, it does not include such an instrument, apparatus, contrivance or article, or a component, part or accessory of any of them, that does any of the actions referred to in paragraphs (a) to (e) solely by pharmacological, immunological or metabolic means or solely by chemical means in or on the body of a human being or animal; (instrument) drug includes any substance or mixture of substances manufactured, sold or represented for use in (a) the diagnosis, treatment, mitigation or prevention of a disease, disorder or abnormal physical state, or its symptoms, in human beings or animals, (b) restoring, correcting or modifying organic functions in human beings or animals, or (c) disinfection in premises in which food is manufactured, prepared or kept; (drogue) food includes any article manufactured, sold or represented for use as food or drink for human beings, chewing gum, and any ingredient that may be mixed with food for any purpose whatever; (aliment) food for a special dietary purpose means a food that has been specially processed or formulated (a) to meet the particular requirements of an individual in whom a physical or physiological condition exists as a result of a disease, disorder or abnormal physical state, or (b) to be the sole or primary source of nutrition for an individual; (alime...Show s. 2 as this bill would leave it · marked up, a reading aid
Reading the change…
Sponsors
- Pat Martin · Primary
Frequently asked questions
- Who sponsors C-220?
- C-220 is sponsored by Pat Martin (NDP).
- What is the current status of C-220?
- This bill died with 38-1 Parliament. It reached “Introduced” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
- Where can I track C-220?
- Track C-220 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on C-220
Find your MP and tell them where you stand on it — or book a meeting about bringing your supporters' voices to the people who decide it.
Stay ahead of C-220
Last checked for changes 4 days ago · updated continuously
One Click Politics tracks every bill in the Parliament of Canada, and in the provinces and territories.
Track this bill →